002349.SZ · 精华制药
China A-shares · RS rating 93 · As of 2026-10-14
| Price | 7.81 CNY |
|---|---|
| 1-day change | -9.8% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 83 / 89 / 77 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 34 / 37 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -1.2% |
| Distance from 52-week high | +15.7% |
| Market cap (USD) | $1.1B |